Maya Sangesland

1.8k total citations
26 papers, 1.0k citations indexed

About

Maya Sangesland is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Maya Sangesland has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Epidemiology and 10 papers in Immunology. Recurrent topics in Maya Sangesland's work include Influenza Virus Research Studies (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Maya Sangesland is often cited by papers focused on Influenza Virus Research Studies (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Maya Sangesland collaborates with scholars based in United States, Canada and Germany. Maya Sangesland's co-authors include Peter S. Rabinovitch, Simon C. Johnson, Matt Kaeberlein, Daniel Lingwood, Anthony S. Castanza, Jessica Hui, Ernst‐Bernhard Kayser, Philip G. Morgan, Valerie Wall and Kelly H. Oh and has published in prestigious journals such as Science, Nature Communications and Immunity.

In The Last Decade

Maya Sangesland

23 papers receiving 1.0k citations

Peers

Countries citing papers authored by Maya Sangesland

Since Specialization

Citations

This map shows the geographic impact of Maya Sangesland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maya Sangesland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maya Sangesland more than expected).

Fields of papers citing papers by Maya Sangesland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maya Sangesland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maya Sangesland. The network helps show where Maya Sangesland may publish in the future.

Co-authorship network of co-authors of Maya Sangesland

This figure shows the co-authorship network connecting the top 25 collaborators of Maya Sangesland. A scholar is included among the top collaborators of Maya Sangesland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maya Sangesland. Maya Sangesland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibody function predicts viral control in newborn monkeys immunised with an influenza virus HA stem nanoparticle 2025 ·Nature Communications ·(unknown), Beth C. Holbrook, (unknown), Rebecca A. Gillespie, Ralph B. D’Agostino, Maya Sangesland, David A. Ornelles, Masaru Kanekiyo, Martha A. Alexander‐Miller	0
2	Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stem 2024 ·Cell Reports ·Sila Ataca, Maya Sangesland, Rebeca de Paiva Fróes Rocha, Alba Torrents de la Peña, Larance Ronsard, Seyhan Boyoglu-Barnum, Rebecca A. Gillespie, Yaroslav Tsybovsky, Tyler Stephens, Syed M. Moin, Julia Lederhofer, Adrian Creanga, Sarah F. Andrews, Ralston M. Barnes, Daniel Rohrer, Nils Lönberg, Barney S. Graham, Andrew B. Ward, Daniel Lingwood, Masaru Kanekiyo	1
3	Antibody-mediated NK cell activation as a correlate of immunity against influenza infection 2023 ·Nature Communications ·Carolyn M. Boudreau, John S. Burke, Ashraf S. Yousif, Maya Sangesland, Sandra Jastrzebski, Chris P. Verschoor, George A. Kuchel, Daniel Lingwood, Harry Kleanthous, (unknown), Victoria Landolfi, Saranya Sridhar, (unknown)	7
4	Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting 2022 ·Cell Reports ·Blake M. Hauser, Maya Sangesland, Kerri St. Denis, Evan C. Lam, James Brett Case, Ian W. Windsor, Jared Feldman, Timothy M. Caradonna, (unknown), Michael Diamond, Alejandro B. Balazs, Daniel Lingwood, Aaron G. Schmidt	15
5	Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design 2022 ·Cell Reports Medicine ·Blake M. Hauser, Jared Feldman, Maya Sangesland, Larance Ronsard, Kerri St. Denis, Maegan L. Sheehan, (unknown), Julie Boucau, Ian W. Windsor, (unknown), (unknown), (unknown), (unknown), Alejandro B. Balazs, Daniel Lingwood, Wilfredo F. García-Beltrán, Aaron G. Schmidt	4
6	Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization 2022 ·Frontiers in Immunology ·Blake M. Hauser, Maya Sangesland, Evan C. Lam, Jared Feldman, Alejandro B. Balazs, Daniel Lingwood, Aaron G. Schmidt	0
7	Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus 2022 ·Immunity ·Maya Sangesland, Alba Torrents de la Peña, Seyhan Boyoglu-Barnum, Larance Ronsard, (unknown), (unknown), Ralston M. Barnes, Daniel Rohrer, Nils Lönberg, Musie Ghebremichael, Masaru Kanekiyo, Andrew B. Ward, Daniel Lingwood	24
8	Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses 2021 ·Science Immunology ·Jared Feldman, Julia Bals, Clara G. Altomare, Kerri St. Denis, Evan C. Lam, Blake M. Hauser, Larance Ronsard, Maya Sangesland, (unknown), (unknown), (unknown), Alejandro B. Balazs, Goran Bajic, Daniel Lingwood, Aaron G. Schmidt	28
9	Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies 2021 ·Frontiers in Immunology ·Maya Sangesland, Daniel Lingwood	4
10	Influenza virus geometry shapes the immune response against it 2020 ·Bulletin of the American Physical Society ·Assaf Amitai, Maya Sangesland, Daniel Lingwood, Arup Chakraborty	0
11	The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells 2020 ·Immunity ·Ashraf S. Yousif, Larance Ronsard, Pankaj R. Shah, Tatsushi Omatsu, Maya Sangesland, (unknown), Evan C. Lam, Vladimir Vrbanac, Alejandro B. Balazs, Hans-Christian Reinecker, Daniel Lingwood	31
12	A Single Human VH-gene Allows for a Broad-Spectrum Antibody Response Targeting Bacterial Lipopolysaccharides in the Blood 2020 ·Cell Reports ·Maya Sangesland, Ashraf S. Yousif, Larance Ronsard, Samuel W. Kazer, Alex Zhu, G. James Gatter, Matthew R. Hayward, Ralston M. Barnes, (unknown), Daniel Rohrer, Nils Lönberg, Douglas S. Kwon, Alex K. Shalek, Daniel Lingwood	19
13	Defining and Manipulating B Cell Immunodominance Hierarchies to Elicit Broadly Neutralizing Antibody Responses against Influenza Virus 2020 ·Cell Systems ·Assaf Amitai, Maya Sangesland, Ralston M. Barnes, Daniel Rohrer, Nils Lönberg, Daniel Lingwood, Arup K. Chakraborty	38
14	Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus 2019 ·Immunity ·Maya Sangesland, Larance Ronsard, Samuel W. Kazer, Julia Bals, Seyhan Boyoglu-Barnum, Ashraf S. Yousif, Ralston M. Barnes, Jared Feldman, (unknown), Patrick M. McTamney, Daniel Rohrer, Nils Lönberg, Bryce Chackerian, Barney S. Graham, Masaru Kanekiyo, Alex K. Shalek, Daniel Lingwood	57
15	Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers 2018 ·Science ·Talar Tokatlian, Benjamin J. Read, Christopher A. Jones, Daniel W. Kulp, Sergey Menis, Jason Y.H. Chang, Jon M. Steichen, Sudha Kumari, Joel D. Allen, Eric L. Dane, Alessia Liguori, Maya Sangesland, Daniel Lingwood, Max Crispin, William R. Schief, Darrell J. Irvine	212
16	Host factors that promote retrotransposon integration are similar in distantly related eukaryotes 2017 ·PLoS Genetics ·Sudhir Kumar, Maya Sangesland, (unknown), Caroline Esnault, (unknown), (unknown), Henry L. Levin	6
17	Qualitative and Quantitative Assays of Transposition and Homologous Recombination of the Retrotransposon Tf1 in Schizosaccharomyces pombe 2016 ·Methods in molecular biology ·Maya Sangesland, (unknown), Sudhir Kumar, Henry L. Levin	6
18	Modulating mTOR in Aging and Health 2014 ·PubMed ·Simon C. Johnson, Maya Sangesland, Matt Kaeberlein, Peter S. Rabinovitch	75
19	mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome 2013 ·Science ·Simon C. Johnson, (unknown), Ernst‐Bernhard Kayser, Albert Quintana, Maya Sangesland, Anthony S. Castanza, (unknown), Jessica Hui, Valerie Wall, (unknown), Kelly H. Oh, Brian M. Wasko, Fresnida J. Ramos, Richard D. Palmiter, Peter S. Rabinovitch, Philip G. Morgan, Margaret M. Sedensky, Matt Kaeberlein	401
20	Cdc42 GTPase and Rac1 GTPase act downstream of p120 catenin and require GTP exchange during gastrulation of zebrafish mesoderm 2012 ·Developmental Dynamics ·Cynthia L. Hsu, (unknown), (unknown), Ryan Walsh, Martha A. Zepeda‐Rivera, (unknown), Maya Sangesland, (unknown), Ju Youn Kim, Patricia Sanchez‐Vazquez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Merrill B. Hille	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact